These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2402873)

  • 1. Oral immunization of foxes with avirulent rabies virus mutants.
    Le Blois H; Tuffereau C; Blancou J; Artois M; Aubert A; Flamand A
    Vet Microbiol; 1990 Jun; 23(1-4):259-66. PubMed ID: 2402873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of SAG1 oral vaccine for the long-term protection of red foxes (Vulpes vulpes) against rabies.
    Artois M; Cliquet F; Barrat J; Schumacher CL
    Vet Rec; 1997 Jan; 140(3):57-9. PubMed ID: 9023904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAG-2 oral rabies vaccine.
    Schumacher CL; Coulon P; Lafay F; Bénéjean J; Aubert MF; Barrat J; Aubert A; Flamand A
    Onderstepoort J Vet Res; 1993 Dec; 60(4):459-62. PubMed ID: 7777336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avirulent mutants of rabies virus and their use as live vaccine.
    Flamand A; Coulon P; Lafay F; Tuffereau C
    Trends Microbiol; 1993 Nov; 1(8):317-20. PubMed ID: 8162418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of foxes Vulpes vulpes by the oral and intramuscular routes with inactivated rabies vaccines.
    Lawson KF; Johnston DH; Patterson JM; Black JG; Rhodes AJ; Zalan E
    Can J Comp Med; 1982 Oct; 46(4):382-5. PubMed ID: 7172102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccination.
    Orłowska A; Żmudziński JF
    Arch Virol; 2015 Feb; 160(2):509-15. PubMed ID: 25408374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of arctic foxes (Alopex lagopus) with oral rabies vaccine.
    Follmann EH; Ritter DG; Baer GM
    J Wildl Dis; 1988 Jul; 24(3):477-83. PubMed ID: 3045347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of three oral rabies vaccine-baits in the red fox: a comparison.
    Artois M; Masson E; Barrat J; Aubert MF
    Vet Microbiol; 1993 Dec; 38(1-2):167-72. PubMed ID: 8128598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies.
    Brochier B; Thomas I; Bauduin B; Leveau T; Pastoret PP; Languet B; Chappuis G; Desmettre P; Blancou J; Artois M
    Vaccine; 1990 Apr; 8(2):101-4. PubMed ID: 2336870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of terrestrial rabies in Western European countries.
    Cliquet F; Aubert M
    Dev Biol (Basel); 2004; 119():185-204. PubMed ID: 15747421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of residual virulence of the Vnukovo-32/107 rabies virus vaccination strain.
    Svrcek S; Ondrejka R; Benísek Z; Vrtiak OJ; Selimov MA; Závadová J; Durove A; Süliová J; Mad'ar M
    Vet Med (Praha); 1995 Feb; 40(2):53-64. PubMed ID: 7740717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F; Robardet E; Picard Meyer E
    Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Annual testing of immunity in foxes after oral rabies immunization].
    Vrzal V; Matouch O
    Vet Med (Praha); 1996 Apr; 41(4):107-11. PubMed ID: 8693662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of animal recombinant DNA vaccine and its efficacy in foxes.
    Kieny MP; Blancou J; Lathe R; Pastoret PP; Soulebot JP; Desmettre P; Lecocq JP
    Rev Infect Dis; 1988; 10 Suppl 4():S799-802. PubMed ID: 3206090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe.
    Masson E; Cliquet F; Aubert M; Barrat J; Aubert A; Artois M; Schumacher CL
    Vaccine; 1996 Nov; 14(16):1506-10. PubMed ID: 9014291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral vaccination in the control of feral rabies].
    Biocca E; Bellani L
    Parassitologia; 1988; 30(1):3-12. PubMed ID: 3268770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a double avirulent mutant of rabies virus and its potency as a vaccine, live or inactivated.
    Tidke R; Préhaud C; Coulon P; Blancou J; Flamand A
    Vaccine; 1987 Sep; 5(3):229-33. PubMed ID: 3673209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan.
    Ito H; Minamoto N; Watanabe T; Goto H; Rong LT; Sugiyama M; Kinjo T; Mannen K; Mifune K; Konobe T
    Microbiol Immunol; 1994; 38(6):479-82. PubMed ID: 7968680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral rabies vaccination: an overview.
    Baer GM
    Rev Infect Dis; 1988; 10 Suppl 4():S644-8. PubMed ID: 3206074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.